" class="no-js "lang="en-US"> C-RAD - Medtech Alert
Tuesday, August 12, 2025
C-RAD | Pharmtech Focus

C-RAD

About C-RAD

C-RAD

Through detailed knowledge about the radiotherapy business and its customer requirements we offer products for positioning, monitoring, tumor localization and radiation therapy. In new advanced radiation therapy techniques, the radiation dose must be delivered to the tumor with extremely high precision and microsecond timing. Our positioning and scanning products assure just that.

Our customers are radiation treatment clinics and diagnostics departments in hospitals worldwide. The aim is to contribute to a higher level of quality and efficiency for the customer.

In June 2015, C-RAD also completed its acquisition of the Franco-Belgian Cyrpa group, which added their innovative laser solutions for patient positioning and virtual simulation to the C-RAD portfolio.

Related Story

C-RAD and Accuray Sign Agreement to Enhance Radixact® System Breast Cancer Treatment Capabilities

October 4 2021

C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed […]